Other News To Note
• Prescience Labs LLC, of Potomac, Md., said the FDA has approved its investigational new drug application for Phase I clinical evaluation of its anti-cancer drug 3-bromopyruvate (PSL-001) in patients with primary and/or metastatic liver cancer. The study will evaluate the dosing regimen of the drug to determine the maximum tolerated dose based on the safety data.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST